# Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies

**Authors:** Yusen Qie, Jiaxin Li, Yang Xu, Sijia Liu, Na Liu, Qing Liu

PMC · DOI: 10.3389/fimmu.2026.1761693 · Frontiers in Immunology · 2026-02-05

## TL;DR

This paper reviews how targeting pyroptosis, a type of cell death, could lead to new treatments for periodontitis, a common gum disease.

## Contribution

The paper provides a comprehensive overview of pyroptosis mechanisms and novel therapeutic strategies for periodontitis.

## Key findings

- Pyroptosis contributes to the progression of periodontitis through pro-inflammatory pathways.
- Targeting pyroptosis offers potential therapeutic approaches like gene regulation and natural compounds.
- Recent advances highlight challenges and translational opportunities in pyroptosis-based therapies.

## Abstract

Periodontitis is a common chronic inflammatory disease of the oral cavity. It is characterized by progressive destruction of the periodontal supporting tissues and alveolar bone loss, and it remains a leading cause of tooth loss in adults. In recent years, pyroptosis, a pro-inflammatory form of programmed cell death, has attracted increasing attention for its role in the initiation and progression of periodontitis. This review summarizes the molecular mechanisms and signaling pathways of pyroptosis. We highlight pyroptosis-targeted therapeutic strategies for periodontitis, including molecular targeted interventions, gene regulation, ion channel blockers, and natural compounds, among others. We also discuss major challenges and translational prospects in light of recent advances. This review aims to provide direction and guidance for developing novel periodontal therapeutic and regenerative strategies by targeting pyroptosis.

## Linked entities

- **Diseases:** periodontitis (MONDO:0005076)

## Full-text entities

- **Genes:** CIITA (class II major histocompatibility complex transactivator) [NCBI Gene 4261] {aka C2TA, CIITAIV, MHC2D1, MHC2TA, NLRA}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, PANX1 (pannexin 1) [NCBI Gene 24145] {aka MRS1, OOMD7, OZEMA7, PX1, UNQ2529}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, IL1R1 (interleukin 1 receptor type 1) [NCBI Gene 3554] {aka CD121A, CRMO3, D2S1473, IL-1R-alpha, IL-1RT1, IL1R}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, TNP1 (transition protein 1) [NCBI Gene 7141] {aka TP1}, Il18 (interleukin 18) [NCBI Gene 29197] {aka IL-1 gamma, IL-18}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, TNFAIP3 (TNF alpha induced protein 3) [NCBI Gene 7128] {aka A20, AIFBL1, AISBL, OTUD7C, TNFA1P2}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Gsdmd (gasdermin D) [NCBI Gene 315084] {aka Gsdmdc1}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, DNM1L (dynamin 1 like) [NCBI Gene 10059] {aka DLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1}, Casp1 (caspase 1) [NCBI Gene 25166] {aka Ice, Il1bc, p45}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Wnt1 (wingless-type MMTV integration site family, member 1) [NCBI Gene 22408] {aka Int-1, Wnt-1, sw, swaying}, ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) [NCBI Gene 953] {aka ATP-DPH, ATPDase, CD39, NTPDase-1, SPG64}, APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317] {aka APAF-1, CED4}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, Mmp8 (matrix metallopeptidase 8) [NCBI Gene 17394], CASP4 (caspase 4) [NCBI Gene 837] {aka CASP-4, ICE(rel)II, ICEREL-II, ICH-2, Mih1, Mih1/TX}, NAIP (NLR family apoptosis inhibitory protein) [NCBI Gene 4671] {aka BIRC1, NLRB1, psiNAIP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ngly1 (N-glycanase 1) [NCBI Gene 59007] {aka 1110002C09Rik, PNGase, Png1}, XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, Slc2a1 (solute carrier family 2 member 1) [NCBI Gene 24778] {aka GLUTB, GTG1, Glut1, Gtg3, RATGTG1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 287362] {aka Cias1}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, Casp4 (caspase 4, apoptosis-related cysteine peptidase) [NCBI Gene 12363] {aka CASP-11, CASP-4, Casp11, Caspl, ich-3}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Ccl25 (C-C motif chemokine ligand 25) [NCBI Gene 20300] {aka A130072A22Rik, CKb15, Scya25, TECK}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) [NCBI Gene 5610] {aka PKR, PPP1R83, PRKR}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CTSG (cathepsin G) [NCBI Gene 1511] {aka CATG, CG}, NLRC4 (NLR family CARD domain containing 4) [NCBI Gene 58484] {aka AIFEC, CARD12, CLAN, CLAN1, CLANA, CLANB}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}
- **Diseases:** damage (MESH:D020263), alveolar (MESH:D002282), bone resorption (MESH:D001862), GSDMD-N (MESH:D014808), microbial (MESH:D015163), tumor (MESH:D009369), diabetes (MESH:D003920), pain (MESH:D010146), mitochondrial injury (MESH:D028361), gout (MESH:D006073), NSPT (MESH:D010518), gingival inflammation (MESH:D007249), endotoxemic shock (MESH:D012769), hyperglycemia (MESH:D006943), periapical periodontitis (MESH:D010485), tooth loss (MESH:D016388), tissue (MESH:D017695), infectious (MESH:D003141), sepsis (MESH:D018805), immune dysregulation (OMIM:614878), periodontal lesions (MESH:D010510), alveolar bone loss (MESH:D016301), cytotoxicity (MESH:D064420), gingival injury (MESH:D005891), bone defects (MESH:D001847), infection (MESH:D007239), chronic periodontitis (MESH:D055113), hyperglycemic (MESH:D006944), hematological abnormalities (MESH:D006402), arthritis (MESH:D001168)
- **Chemicals:** A-740003 (MESH:C515928), Dapansutrile (MESH:C000627877), MCC950 (MESH:C000597426), terpenoids (MESH:D013729), purines (MESH:D011687), ADP (MESH:D000244), Belnacasan (MESH:C520022), BBG (MESH:C004692), lipoxin A4 (MESH:C040527), Metal-Organic Framework (MESH:D000073396), NSA (MESH:C570695), Quercetin (MESH:D011794), Z-VAD-fmk (MESH:C096713), PEG (MESH:D011092), acid (MESH:D000143), Zn (MESH:D015032), sodium alginate (MESH:D000464), metal (MESH:D008670), Vitamin D (MESH:D014807), Ac-YVAD-cmk (MESH:C098738), flavonoids (MESH:D005419), Mg (MESH:D008274), glucose (MESH:D005947), ROS (MESH:D017382), BML-111 (MESH:C530770), PLGA (MESH:D000077182), N-acetylcysteine (MESH:D000111), hydrogen (MESH:D006859), cysteine (MESH:D003545), lipids (MESH:D008055), LPS (MESH:D008070), ATP (MESH:D000255), polyphenols (MESH:D059808), BzATP (MESH:C033901), Capsaicin (MESH:D002211), PEG-PLGA (MESH:C000589473), Cyclic GMP-AMP (MESH:C584311), K+ (MESH:D011188), MOF (MESH:C037042), AZ10606120 (MESH:C000602458), Na+ (MESH:D012964), Ca2+ (-), DSF (MESH:D004221)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Treponema denticola (species) [taxon 158], Homo sapiens (human, species) [taxon 9606], Tannerella forsythia (species) [taxon 28112], Rattus norvegicus (brown rat, species) [taxon 10116], Porphyromonas gingivalis (species) [taxon 837]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MCC950 — Homo sapiens (Human), Scleromyxedema, Finite cell line (CVCL_IL06), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916366/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916366/full.md

## References

174 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916366/full.md

---
Source: https://tomesphere.com/paper/PMC12916366